

Foundayo is one of the top-rated GLP-1 medication provider offering orforglipron for weight loss. With an exceptional 9.2/10 rating, Foundayo has established itself as one of the most trusted providers in the GLP-1 space. With a monthly price of just $149, Foundayo positions itself as an affordable option in the competitive GLP-1 market.
The platform stands out for its exceptional service quality and comprehensive approach to weight loss. Their focus on orforglipron allows them to streamline their service and potentially offer competitive pricing. Whether you've been researching Foundayo reviews, Foundayo reviews complaints, or asking "is Foundayo legit," you'll find that Foundayo delivers legitimate, high-quality telemedicine services with licensed healthcare providers.
Foundayo does not publish a customer phone number on its website; support runs through your account, not published. Foundayo operates with full transparency, HIPAA compliance, and a commitment to helping patients achieve their weight loss goals safely and effectively.
After reviewing all 148 providers on this platform, we've identified CoreAge Rx as offering the most transparent pricing model. At just $99/month — the same price every month, every dose — there are no surprise charges or hidden fees. Combined with exceptional service quality, personalized support, and access to both semaglutide and tirzepatide, it represents the best value without compromising on care.
None - there is no membership, this is a prescription medicine bought per fill
Self-pay starts at $149 per month for the lowest dose through LillyDirect. Eligible commercial insurance patients may pay as little as $25 per month with the Foundayo savings card. Eligible Medicare Part D patients may pay $50 per month from as early as 1 July 2026.
At $149/month, Foundayo offers one of the most competitive pricing options in the GLP-1 market. This makes it an attractive choice for those looking for affordable access to weight loss medications.
Fill out a comprehensive medical questionnaire about your health history, weight loss goals, and current medications.
A licensed healthcare provider reviews your information and determines if GLP-1 medication is right for you.
Your prescription is shipped directly to your door with clear instructions and ongoing support.
What follows is what Foundayo states on its own website. Where the company does not publish an answer, we say so rather than assume the industry norm applies.
Brand-name and FDA-approved. Foundayo is Eli Lilly's own product, approved by the FDA on 1 April 2026 for adults with obesity, or adults with overweight who also have weight-related medical problems. Orforglipron was discovered by Chugai Pharmaceutical and licensed by Lilly in 2018. There is no legal compounded version of orforglipron.
Adults with obesity, or adults with overweight who also have weight-related medical problems, used alongside a reduced-calorie diet and increased physical activity. Contraindicated if you or a family member has ever had medullary thyroid carcinoma, if you have MEN 2, or if you have had a serious allergic reaction to orforglipron. Not established as safe or effective in children.
A prescription is required. Lilly says prescriptions are accepted through LillyDirect, with broad availability through US retail pharmacies and telehealth providers following the launch. The prescriber is your own clinician or one you reach through a telehealth partner, not Lilly.
Not specified by Lilly; monitoring is at your prescriber's discretion.
Dispensed through LillyDirect with free home delivery, and through US retail pharmacies and telehealth providers.
Home delivery through LillyDirect; one-month supplies
Savings card support and prescribing information published by Lilly
Orforglipron (brand name Foundayo) is a once-daily small-molecule GLP-1 pill from Eli Lilly, approved by the FDA on 1 April 2026. Unlike oral semaglutide it can be taken at any time of day with no food or water restrictions. In the ATTAIN-1 trial, participants on the highest dose who stayed on treatment lost an average of 12.4% of body weight (27.3 pounds) against 0.9% on placebo.
Foundayo is particularly well-suited for:
Not published
Not published
Not available
Not published
None published; this is a prescription medicine, not a subscription service
Prescription-based - stopping treatment is a decision for you and your prescriber
Not applicable - dispensed prescription medication is not returnable
Foundayo works with insurance, though coverage for weight-loss medication depends on your specific plan and often requires prior authorisation. Prescription medication is generally an eligible HSA/FSA expense; confirm with your plan administrator.
Yes, Foundayo is a legitimate telemedicine provider offering GLP-1 medications for weight loss. Foundayo operates with licensed healthcare providers and follows all regulatory requirements for prescribing and dispensing medications. With a 9.2/10 rating, Foundayo has established itself as one of the most trusted providers in the GLP-1 space.
Many people ask "is Foundayo legitimate?" or "is Foundayo a scam?" - these concerns are natural when considering online healthcare services. However, Foundayo is a fully legitimate medical service that employs licensed physicians, maintains HIPAA compliance, and dispenses authentic FDA-approved medications.
Foundayo offers orforglipron as part of their Foundayo GLP-1 medication program:
Foundayo GLP-1 medication is available at the competitive price of $149/month, making it accessible for most patients seeking weight loss treatment.
You can reach Foundayo through multiple channels:
The Foundayo customer support team is available Not published to answer your questions about their GLP-1 weight loss programs.
Adults with obesity, or adults with overweight who also have weight-related medical problems, used alongside a reduced-calorie diet and increased physical activity. Contraindicated if you or a family member has ever had medullary thyroid carcinoma, if you have MEN 2, or if you have had a serious allergic reaction to orforglipron. Not established as safe or effective in children.
Not specified by Lilly; monitoring is at your prescriber's discretion.
Brand-name and FDA-approved. Foundayo is Eli Lilly's own product, approved by the FDA on 1 April 2026 for adults with obesity, or adults with overweight who also have weight-related medical problems. Orforglipron was discovered by Chugai Pharmaceutical and licensed by Lilly in 2018. There is no legal compounded version of orforglipron.
Dispensed through LillyDirect with free home delivery, and through US retail pharmacies and telehealth providers.
Self-pay starts at $149 per month for the lowest dose through LillyDirect. Eligible commercial insurance patients may pay as little as $25 per month with the Foundayo savings card. Eligible Medicare Part D patients may pay $50 per month from as early as 1 July 2026. Membership fee: None - there is no membership, this is a prescription medicine bought per fill
Not applicable - dispensed prescription medication is not returnable
Prescription medication is generally an eligible HSA/FSA expense; confirm with your plan administrator.
When researching "Foundayo reviews," it's important to look at multiple sources. Here's what we found about Foundayo reviews and complaints:
Foundayo has earned an exceptional 9.2/10 rating based on pricing, service quality, medication options, and customer support. This places Foundayo among the top-rated GLP-1 providers in the market.
Like any healthcare provider, some customers search for "Foundayo reviews complaints" or "Foundayo reviews and complaints" to understand potential issues. While Foundayo maintains a strong reputation, here's what to know:
When searching for "Foundayo reviews Consumer Reports" or "Foundayo reviews consumer reports complaints," remember that independent review platforms provide valuable insights. Foundayo's high rating of 9.2/10 reflects consistent positive feedback across multiple evaluation criteria.
Whether you're searching for "Foundayo reviews" or "Foundayo reviews complaints," our comprehensive analysis shows that Foundayo delivers on its promises of affordable, high-quality GLP-1 weight loss medication with excellent customer support.
If Foundayo is not the right fit, these providers are the closest comparisons on medication and price. Each links to its own review, or you can put the two side by side.
Foundayo is a medicine, not a care programme. There is no coaching, no dietitian and no ongoing telehealth relationship attached to the product itself - you need a prescriber for that.
What the trials actually showed, how the two drugs differ, and which one suits which patient.
What compounded actually means, why the price gap has narrowed, and the questions to ask first.
Every pricing model in the market, decoded - and why the advertised number is rarely the real one.
The BMI thresholds, the contraindications that rule people out, and what providers actually check.
This review is editorial research, not medical advice. GLP-1 medications are prescription drugs with real risks and contraindications, and nothing here should be used to decide whether to start, stop or change a treatment. Only a licensed clinician who knows your history can tell you whether Foundayo - or any GLP-1 medication - is appropriate for you. If you think you are having a serious reaction to a medication, contact a healthcare professional or emergency services.
Prices, policies and medication availability change often in this market. We report what Foundayo published on its own site at the time of review; confirm the current terms with the provider before you buy.